Case ID: | 130701267 | |
Case Caption: | TROTTER ETAL VS JANSSEN PHARMACEUTICALS, INC. ETAL | |
Filing Date: | Tuesday , July 09th, 2013 | |
Court: | MT - MASS TORT | |
Location: | CH - CITY HALL | |
Jury: | J - JURY | |
Case Type: | XE - MASS TORT - RISPERDAL | |
Status: | WSPTJ - SETTLED PRIOR TO ASSGN TRL JUD |
Seq # | Assoc | Expn Date | Type | ID | Name |
---|---|---|---|---|---|
1 | 02-APR-2014 | ATTORNEY FOR PLAINTIFF | A81437 | MCCORMICK JR, BRIAN J | |
Address: | ROSS FELLER CASEY LLP
1650 MARKET STREE SUITE 3450 PHILADELPHIA PA 19103 (215)231-3740 (215)231-3750 - FAX | Aliases: | none | ||
2 | 12 | MINOR - PLAINTIFF | @7502099 | J.T., | |
Address: | 1057 WESTWAY STREET
JACKSON MS 39212 | Aliases: | none | ||
3 | 12 | PLAINTIFF | @7502100 | TROTTER, AUNDREA | |
Address: | 1057 WESTWAY STREET
JACKSON MS 39212 | Aliases: | none | ||
4 | 9 | DEFENDANT | @7502101 | JANSSEN PHARMACEUTICALS INC | |
Address: | 1125 TRENTON-HARBOURTON ROAD
TITUSVILLE NJ 08560 | Aliases: | none | ||
5 | 9 | DEFENDANT | @7502102 | JOHNSON & JOHNSON COMPANY | |
Address: | ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK NJ 08933 | Aliases: | none | ||
6 | 9 | DEFENDANT | @7502103 | JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L | |
Address: | 920 ROUTE 202
RARITAN NJ 08869 | Aliases: | none | ||
7 | 20-SEP-2016 | DEFENDANT | @7502104 | EXCERPTA MEDICA INC | |
Address: | 685 US-202
BRIDGEWATER NJ 08807 | Aliases: | none | ||
8 | 20-SEP-2016 | DEFENDANT | @7502105 | ELSEVIER INC | |
Address: | 2 NEWTOWN PLACE, SUITE 350
NEWTOWN MA 02458-1637 | Aliases: | none | ||
9 | ATTORNEY FOR DEFENDANT | A90363 | MERK, MELISSA A | ||
Address: | KLINE & SPECTER, PC
1525 LOCUST ST. PHILADELPHIA PA 19102 (215)792-5618 (215)402-2357 - FAX | Aliases: | none | ||
10 | 9 | ATTORNEY FOR DEFENDANT | A58162 | MURPHY, KENNETH A | |
Address: | TUCKER LAW GROUP, LLC
1801 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103-6996 (215)875-0609 (215)559-6209 - FAX | Aliases: | none | ||
11 | 1 | ATTORNEY FOR PLAINTIFF | A28895 | KLINE, THOMAS R | |
Address: | KLINE & SPECTER
1525 LOCUST ST., 19TH FL. PHILADELPHIA PA 19102 (215)772-1000 (215)772-1359 - FAX | Aliases: | none | ||
12 | ATTORNEY FOR PLAINTIFF | A82899 | GOMEZ, CHRISTOPHER A | ||
Address: | 1525 LOCUST STREET
19TH FLOOR PHILADELPHIA PA 19102 (215)772-1000 (215)735-0921 - FAX | Aliases: | none | ||
13 | TEAM LEADER | J357 | NEW, ARNOLD L | ||
Address: | 606 CITY HALL
PHILADELPHIA PA 19107 (215)686-7260 | Aliases: | none | ||
14 | 12 | ATTORNEY FOR PLAINTIFF | A308526 | ITKIN, JASON A | |
Address: | ARNOLD & ITKIN LLP
6009 MEMORIAL HOUSTON TX 77007 (713)222-3800 | Aliases: | none | ||
15 | 9 | ATTORNEY FOR DEFENDANT | A309232 | REEVE, ANDREW P | |
Address: | FAEGRE DRINKER BIDDLE & REATH
ONE LOGAN SQUARE 130 N. 18TH ST, SUITE 2000 PHILADELPHIA PA 19103 (215)988-3337 (215)988-2757 - FAX | Aliases: | none | ||
16 | ATTORNEY PRO HAC VICE | @9173839 | SELLERS, KALA | ||
Address: | 6009 MEMORIAL DRIVE
HOUSTON TX 77007 | Aliases: | none | ||
17 | 9 | ATTORNEY FOR DEFENDANT | A36666 | ABERNETHY, DAVID F | |
Address: | ONE LOGAN SQUARE, STE. 2000
PHILADELPHIA PA 19103 (215)988-2503 (215)988-2757 - FAX | Aliases: | none | ||
18 | ATTORNEY FOR DEFENDANT | A40466 | KELLY, MICHAEL | ||
Address: | 405 N. KING STREET, 8TH FLOOR
WILMINGTON DE 19801 (302)984-6300 (302)984-6309 - FAX | Aliases: | none | ||
19 | ATTORNEY PRO HAC VICE | @9284973 | BROWN, DANIEL | ||
Address: | MCCARTER & ENGLISH LLP
405 N KING ST RENAISSANCE CENTER, 8TH FLOOR WILMINGTON DE 19801 | Aliases: | none | ||
20 | ATTORNEY PRO HAC VICE | @9284986 | WOOD, STEVEN | ||
Address: | MCCARTER & ENGLISH LLP
405 N KING ST RENAISSANCE CENTER, 8TH FLOOR WILMINGTON DE 19801 | Aliases: | none | ||
21 | 12 | ATTORNEY FOR PLAINTIFF | A3270 | SHELLER, STEPHEN A | |
Address: | SHELLER, P.C.
1515 MARKET STREET SUITE 1100 PHILADELPHIA PA 19102 (215)790-7300 (215)790-7313 - FAX | Aliases: | none | ||
22 | ATTORNEY PRO HAC VICE | @10351644 | JOHNSON, ETHEL J | ||
Address: | MORGAN LEWIS & BOCKIUS LLP
1000 LOUISIANA ST SUITE 4000 HOUSTON TX 77002 | Aliases: | none |
Filing Date/Time | Docket Type | Filing Party | Disposition Amount |
---|---|---|---|
09-JUL-2013
08:59 AM | ACTIV - ACTIVE CASE | ||
Docket Entry: | E-Filing Number: 1307012280 | ||
09-JUL-2013
08:59 AM | CIVIL - COMMENCEMENT OF CIVIL ACTION | MCCORMICK JR, BRIAN J | |
Docket Entry: | none. | ||
09-JUL-2013
08:59 AM | CMPLT - COMPLAINT FILED NOTICE GIVEN | MCCORMICK JR, BRIAN J | |
Docket Entry: | COMPLAINT WITH NOTICE TO DEFEND WITHIN TWENTY (20) DAYS AFTER SERVICE IN ACCORDANCE WITH RULE 1018.1 FILED. | ||
09-JUL-2013
08:59 AM | SSCG5 - SHERIFF'S SURCHARGE 5 DEFTS | MCCORMICK JR, BRIAN J | |
Docket Entry: | none. | ||
09-JUL-2013
08:59 AM | CLWMT - WAITING FOR LISTING MASS TORT | MCCORMICK JR, BRIAN J | |
Docket Entry: | none. | ||
18-JUL-2013
02:22 PM | PRSBV - PRAECIPE-ATTACH VERIFICATION | MCCORMICK JR, BRIAN J | |
Docket Entry: | PRAECIPE TO SUBSTITUTE/ATTACH VERIFICATION FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
16-AUG-2013
12:42 PM | ENAPP - ENTRY OF APPEARANCE | MERK, MELISSA A | |
Docket Entry: | ENTRY OF APPEARANCE OF MELISSA A GRAFF AND KENNETH A MURPHY FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
16-AUG-2013
12:42 PM | JURYT - JURY TRIAL PERFECTED | ||
Docket Entry: | 12 JURORS REQUESTED. | ||
16-AUG-2013
01:47 PM | ENAPP - ENTRY OF APPEARANCE | MERK, MELISSA A | |
Docket Entry: | ENTRY OF APPEARANCE OF MELISSA A GRAFF AND KENNETH A MURPHY FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
28-MAR-2014
01:40 PM | ENAPC - ENTRY OF APPEARANCE-CO COUNSEL | KLINE, THOMAS R | |
Docket Entry: | ENTRY OF APPEARANCE OF THOMAS R KLINE AS CO-COUNSEL FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
02-APR-2014
09:35 AM | WTAPP - WITHDRAWAL/ENTRY OF APPEARANCE | GOMEZ, CHRISTOPHER A | |
Docket Entry: | WITHDRAWAL OF APPEARANCE OF BRIAN J MCCORMICK AND ENTRY OF APPEARANCE OF CHRISTOPHER A GOMEZ FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
26-MAY-2016
09:02 AM | ENAPP - ENTRY OF APPEARANCE | ITKIN, JASON A | |
Docket Entry: | ENTRY OF APPEARANCE OF JASON A ITKIN FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
26-MAY-2016
09:02 AM | JURYT - JURY TRIAL PERFECTED | ||
Docket Entry: | 12 JURORS REQUESTED. | ||
01-JUN-2016
10:23 AM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | CASE MANAGEMENT ORDER ENTERED. SEE ORDER FOR TERMS. TRIAL DATE - 2/6/17, WITH JURY SELECTION ON 2/2/17. BY THE COURT ...NEW,J 6/1/16 | ||
01-JUN-2016
10:23 AM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 01-JUN-2016 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 01-JUN-2016. | ||
01-JUN-2016
10:23 AM | CLLTR - LISTED FOR TRIAL | ||
Docket Entry: | none. | ||
25-AUG-2016
02:29 PM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | AND NOW, THIS 23RD DAY OF AUGUST, 2016, THE COURT HEREBY ENTERS THE FOLLOWING CASE MANAGEMENT ORDER GOVERNING PRETRIAL DEADLINES IN THIS MATTER. JURY SELECTION 3/16/17. TRIAL 3/20/17. BY THE COURT: NEW, J. 8/23/16. | ||
25-AUG-2016
02:29 PM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 26-AUG-2016 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 25-AUG-2016. | ||
25-AUG-2016
02:33 PM | CLWTR - WAITING TO LIST FOR TRIAL | ||
Docket Entry: | none. | ||
25-AUG-2016
02:34 PM | CLLTR - LISTED FOR TRIAL | ||
Docket Entry: | none. | ||
20-SEP-2016
10:37 AM | DISPF - PARTIAL DISCONTINUANCE FILED | GOMEZ, CHRISTOPHER A | |
Docket Entry: | ORDER TO DISCONTINUE AS TO EXCERPTA MEDICA INCORPORATED AND ELSEVIER, INC. WITH PREJUDICE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
15-NOV-2016
11:34 AM | ENAPC - ENTRY OF APPEARANCE-CO COUNSEL | REEVE, ANDREW P | |
Docket Entry: | ENTRY OF APPEARANCE OF ANDREW P REEVE AS CO-COUNSEL FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
21-NOV-2016
07:52 PM | MTPHV - MOT-FOR ADMISSION PRO HAC VICE | ITKIN, JASON A | |
Docket Entry: | 99-16112799 (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
22-NOV-2016
10:53 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 99-16112799 MOT-FOR ADMISSION PRO HAC VICE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: NOVEMBER 22, 2016 | ||
01-DEC-2016
02:11 PM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | 99-16112799 AND NOW, THIS 30TH DAY OF NOVEMBER, 2016, IT IS HEREBY ORDERED AND DECREED THAT THE MOTION FOR ADMISSION PRO HAC VICE IS GRANTED, AND KALA SELLERS, ESQUIRE, TEXAS BAR NO. 24087519, OF ARNOLD & ITKIN LLP, 6009 MEMORIAL DRIVE, HOUSTON, TX 77007, IS HEREBY ADMITTED PRO HAC VICE FOR PURPOSES OF THIS MATTER AFTER OBTAINING THE APPROPRIATE CITY OF PHILADELPHIA BUSINESS PRIVILEGE TAX LICENSE PURSUANT TO 19-2602 OF THE PHILADELPHIA CODE. PRO HAC VICE COUNSEL SHALL PAY ALL CITY BUSINESS AND WAGE TAX AS REQUIRED. BY THE COURT: NEW, J. 11/30/16. | ||
01-DEC-2016
02:11 PM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 02-DEC-2016 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 01-DEC-2016. | ||
18-JAN-2017
02:30 PM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | THIRD AMENDED CASE MANAGEMENT ORDER ENTERED. TRIAL - 4/24/17, WITH JURY SELECTION ON 4/20/17. SEE ORDER FOR COMPLETE TERMS. BY THE COURT ...NEW,J 1/13/17 | ||
18-JAN-2017
02:30 PM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 19-JAN-2017 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 18-JAN-2017. | ||
18-JAN-2017
02:31 PM | CLRBC - CASE RESCHEDULED BY COURT | ||
Docket Entry: | none. | ||
18-JAN-2017
02:31 PM | CLLTR - LISTED FOR TRIAL | ||
Docket Entry: | none. | ||
22-FEB-2017
01:55 PM | ENAPC - ENTRY OF APPEARANCE-CO COUNSEL | ABERNETHY, DAVID F | |
Docket Entry: | ENTRY OF APPEARANCE OF DAVID F ABERNETHY AS CO-COUNSEL FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
23-FEB-2017
01:47 PM | ENAPP - ENTRY OF APPEARANCE | KELLY, MICHAEL | |
Docket Entry: | ENTRY OF APPEARANCE OF MICHAEL KELLY FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
23-FEB-2017
03:58 PM | MTPHV - MOT-FOR ADMISSION PRO HAC VICE | KELLY, MICHAEL | |
Docket Entry: | 26-17023226 UNOPPOSED (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
23-FEB-2017
04:12 PM | MTPHV - MOT-FOR ADMISSION PRO HAC VICE | KELLY, MICHAEL | |
Docket Entry: | 28-17023228 UNOPPOSED (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-FEB-2017
03:05 PM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 26-17023226 MOT-FOR ADMISSION PRO HAC VICE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: FEBRUARY 24, 2017 | ||
24-FEB-2017
03:05 PM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 28-17023228 MOT-FOR ADMISSION PRO HAC VICE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: FEBRUARY 24, 2017 | ||
28-FEB-2017
02:40 PM | ENAPC - ENTRY OF APPEARANCE-CO COUNSEL | SHELLER, STEPHEN A | |
Docket Entry: | ENTRY OF APPEARANCE OF STEPHEN A SHELLER AS CO-COUNSEL FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
28-FEB-2017
04:15 PM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | 28-17023228 IT IS ORDERED THAT DANIEL BROWN ESQ IS ADMITTED PRO HAC VICE FOR PURPOSES OF THIS MATTER AFTER OBTAINING THE APPROPRIATE CITY OF PHILA BUSINESS PRIVILEGE TAX LICENSE PURSUANT TO 19-2602 OF THE PHILA CODE. PRO HAC VICE COUNSEL SHALL PAY ALL CITY BUSINESS AND WAGE TAX AS REQUIRED. BY THE COURT ...NEW,J 2/28/17 | ||
28-FEB-2017
04:15 PM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 01-MAR-2017 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 28-FEB-2017. | ||
28-FEB-2017
04:32 PM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | 26-17023226 IT IS ORDERED THAT STEVEN WOOD ESQ IS ADMITTED PRO HAC VICE FOR PURPOSES OF THIS MATTER AFTER OBTAINING THE APPROPRIATE CITY OF PHILA BUSINESS PRIVILEGE TAX LICENSE PURSUANT TO 19-2602 OF THE PHILA CODE. PRO HAC VICE COUNSEL SHALL PAY ALL CITY BUSINESS AND WAGE TAX AS REQUIRED. BY THE COURT ...NEW,J 2/28/17 | ||
28-FEB-2017
04:32 PM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 01-MAR-2017 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 28-FEB-2017. | ||
13-MAR-2017
02:33 PM | MTSAN - MOTION FOR SANCTIONS | ABERNETHY, DAVID F | |
Docket Entry: | 54-17031954 RESPONSE DATE 03/20/2017. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
20-MAR-2017
06:37 PM | PRATT - PRAECIPE TO SUPPL/ATTACH FILED | ABERNETHY, DAVID F | |
Docket Entry: | 54-17031954 PRAECIPE TO SUPPLEMENT/ATTACH RE: MOTION FOR SANCTIONS FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
20-MAR-2017
07:11 PM | MTSJD - MOTION FOR SUMMARY JUDGMENT | ABERNETHY, DAVID F | |
Docket Entry: | 88-17032988 RESPONSE DATE 04/10/2017. REPLY DATE: APRIL 17TH, 2017 (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
20-MAR-2017
07:41 PM | WITEX - WITNESS/EXHIBIT LIST FILED | MERK, MELISSA A | |
Docket Entry: | WITNESS AND EXHIBIT LIST FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
20-MAR-2017
07:44 PM | DEPDN - DEPOSITION DESIGNATIONS | MERK, MELISSA A | |
Docket Entry: | DEPOSITION DESIGNATIONS FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
20-MAR-2017
10:16 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 54-17031954 ANSWER IN OPPOSITION OF MOTION FOR SANCTIONS FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
20-MAR-2017
11:10 PM | WITEX - WITNESS/EXHIBIT LIST FILED | ITKIN, JASON A | |
Docket Entry: | WITNESS AND EXHIBIT LIST FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
20-MAR-2017
11:13 PM | DEPDN - DEPOSITION DESIGNATIONS | ITKIN, JASON A | |
Docket Entry: | DEPOSITION DESIGNATIONS FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
22-MAR-2017
01:42 PM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 54-17031954 MOTION FOR SANCTIONS ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: MARCH 22, 2017 | ||
27-MAR-2017
05:17 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 54-17031954 REPLY IN SUPPORT OF MOTION FOR SANCTIONS FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
29-MAR-2017
12:07 PM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | 54-17031954 IT IS ORDERED THAT DEFTS, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON AND JANSSEN RESEARCH AND DEVELOPMENT LLC'S MOTION FOR SANCTIONS IS GRANTED IN PART AS FOLLOWS: THE TRIAL IN THIS MATTER, CURRENTLY SCHEDULED FOR 4/24/17 IS HEREBY CONTINUED; AND, THIS CASE SHALL BE REMOVED FROM THE "LISTED FOR TRIAL" STATUS AND PLACED INTO "WAITING FOR LISTING MASS TORT" STATUS. BY THE COURT ...NEW,J 3/28/17 | ||
29-MAR-2017
12:07 PM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 30-MAR-2017 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 29-MAR-2017. | ||
29-MAR-2017
12:25 PM | CLWMT - WAITING FOR LISTING MASS TORT | ||
Docket Entry: | none. | ||
12-APR-2017
01:26 PM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 88-17032988 MOTION FOR SUMMARY JUDGMENT ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: APRIL 12, 2017 | ||
24-APR-2017
09:53 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 88-17032988 ANSWER IN OPPOSITION OF MOTION FOR SUMMARY JUDGMENT FILED. (FILED ON BEHALF OF J.T.) | ||
05-MAY-2017
07:54 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 88-17032988 REPLY IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
20-JUN-2017
01:45 PM | MTWTD - MOTION/PETITION/STIP WITHDRAWN | ABERNETHY, DAVID F | |
Docket Entry: | 88-17032988 PRAECIPE TO WITHDRAW MOTION FOR SUMMARY JUDGMENT FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
30-NOV-2017
12:08 PM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | CASE MANAGEMENT ORDER ENTERED. TRIAL LISTED FOR 10/22/18 WITH JURY SELECTION ON 10/18/18. SEE ORDER FOR COMPLETE TERMS. BY THE COURT ...NEW,J 11/29/17 | ||
30-NOV-2017
12:08 PM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 01-DEC-2017 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 30-NOV-2017. | ||
30-NOV-2017
12:10 PM | CLLTR - LISTED FOR TRIAL | ||
Docket Entry: | none. | ||
02-JUL-2018
05:11 PM | MTSJD - MOTION FOR SUMMARY JUDGMENT | ABERNETHY, DAVID F | |
Docket Entry: | 97-18070297 RESPONSE DATE 07/23/2018. REPLY DATE 07/30/2018. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
23-JUL-2018
10:51 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 97-18070297 ANSWER IN OPPOSITION OF MOTION FOR SUMMARY JUDGMENT FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-JUL-2018
03:18 PM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 97-18070297 MOTION FOR SUMMARY JUDGMENT ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: JULY 25, 2018 | ||
06-AUG-2018
02:36 PM | MTPHV - MOT-FOR ADMISSION PRO HAC VICE | MERK, MELISSA A | |
Docket Entry: | 80-18080680 (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
06-AUG-2018
03:26 PM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 80-18080680 MOT-FOR ADMISSION PRO HAC VICE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: AUGUST 06, 2018 | ||
08-AUG-2018
09:42 AM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 97-18070297 REPLY IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
08-AUG-2018
02:37 PM | PRATT - PRAECIPE TO SUPPL/ATTACH FILED | ABERNETHY, DAVID F | |
Docket Entry: | 97-18070297 PRAECIPE TO SUPPLEMENT/ATTACH RE: REPLY IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
16-AUG-2018
10:22 AM | ORDER - ORDER ENTERED/236 NOTICE GIVEN | NEW, ARNOLD L | |
Docket Entry: | 80-18080680 IT IS ORDERED THAT ETHEL JOHNSON ESQ IS ADMITTED PRO HAC VICE FOR PURPOSES OF THIS MATTER AFTER OBTAINING THE APPROPRIATE CITY OF PHILA BUSINESS PRIVILEGE TAX LICENSE PURSUANT TO 19-2602 OF THE PHILA CODE. PRO HAC VICE COUNSEL SHALL PAY ALL CITY BUSINESS AND WAGE TAX AS REQUIRED. BY THE COURT ...NEW,J 8/15/18 | ||
16-AUG-2018
10:22 AM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 17-AUG-2018 OF ORDER ENTERED/236 NOTICE GIVEN ENTERED ON 16-AUG-2018. | ||
10-SEP-2018
05:03 PM | DEPDN - DEPOSITION DESIGNATIONS | MERK, MELISSA A | |
Docket Entry: | DEPOSITION DESIGNATIONS FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
10-SEP-2018
05:07 PM | WITEX - WITNESS/EXHIBIT LIST FILED | MERK, MELISSA A | |
Docket Entry: | WITNESS LIST FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
10-SEP-2018
07:19 PM | WITEX - WITNESS/EXHIBIT LIST FILED | MERK, MELISSA A | |
Docket Entry: | EXHIBIT LIST FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
10-SEP-2018
09:41 PM | DEPDN - DEPOSITION DESIGNATIONS | ITKIN, JASON A | |
Docket Entry: | DEPOSITION DESIGNATIONS FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
10-SEP-2018
09:48 PM | WITEX - WITNESS/EXHIBIT LIST FILED | ITKIN, JASON A | |
Docket Entry: | WITNESS AND EXHIBIT LIST FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
24-SEP-2018
03:54 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 87-18092787 MOTION IN LIMINE MOTION IN LIMINE NO. 1 TO EXCLUDE ANY EVIDENCE THAT INFORMATION RELEVANT TO RISKS ASSOCIATED WITH RISPERDAL (INCLUDING ?TABLE 21? AND RELATED INFORMATION) (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:00 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 93-18092793 MOTION IN LIMINE MOTION IN LIMINE NO. 2 TO REQUIRE PRODUCTION OF ADDITIONAL INFORMATION ON EXPERT WITNESS OR, IN THE ALTERNATIVE, TO PRECLUDE CERTAIN BIAS EVIDENCE (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:03 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 94-18092794 MOTION IN LIMINE MOTION IN LIMINE NO. 3 TO PROHIBIT REFERENCES TO DOCUMENTS PRODUCED IN DISCOVERY AS ?CONFIDENTIAL? OR TO ANY DOCUMENTS THAT ARE NOT PUBLICALLY DISSEMINATED (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:07 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 95-18092795 MOTION IN LIMINE MOTION IN LIMINE NO. 4 TO EXCLUDE ANY EVIDENCE OF PLAINTIFF J.T.?S DECEASED FATHER OR DAUGHTER (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:10 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 96-18092796 MOTION IN LIMINE MOTION IN LIMINE NO. 5 TO PRECLUDE ANY EXPERT OPINION BY MARK P. SOLOMON, MD, THAT IS BEYOND THE SCOPE OF HIS EXPERT REPORTS (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:14 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 97-18092797 MOTION IN LIMINE MOTION IN LIMINE NO. 6 TO PRECLUDE EVIDENCE OF MARKETING MATERIALS AND BUSINESS PLANS (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:17 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 98-18092798 MOTION IN LIMINE MOTION IN LIMINE NO. 7 TO PRECLUDE PLAINTIFFS FROM REFERRING TO ANY POTENTIAL SURGERY AS A ?MASTECTOMY? OR ?DOUBLE MASTECTOMY? (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:20 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 99-18092799 MOTION IN LIMINE MOTION IN LIMINE NO. 8 TO EXCLUDE EVIDENCE AND ARGUMENT THAT IS IRRELEVANT TO THE PRESCRIBING DECISIONS AND WARNINGS IN THIS CASE, INCLUDING MATERIALS THAT DID (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:23 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 00-18092800 MOTION IN LIMINE MOTION IN LIMINE NO. 9 REGARDING ALLEGED OFF-LABEL PROMOTION AND THE FIRST AMENDMENT (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:27 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 01-18092801 MOTION IN LIMINE MOTION IN LIMINE NO. 10 TO PRECLUDE TESTIMONY OF PHYSICIANS WHO PRESCRIBED RISPERDAL FOR PLAINTIFF J.T. AFTER HE CLAIMS THAT HE WAS INJURED (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
04:30 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 02-18092802 MOTION IN LIMINE MOTION IN LIMINE NO. 11 TO EXCLUDE EVIDENCE OF DEFENDANTS? WEALTH, SALES, AND/OR PROFITS (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
24-SEP-2018
11:56 PM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 04-18092804 MOTION IN LIMINE MOTION IN LIMINE TO EXCLUDE EVIDENCE RELATING TO STATEMENTS THAT GOOD PEOPLE WORK AT THE FDA AND/OR FOR DEFENDANTS (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
24-SEP-2018
11:58 PM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 05-18092805 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 2 TO EXCLUDE CERTAIN SUBJECTS FROM EVIDENCE AT TRIAL (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:00 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 06-18092806 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 3 TO EXCLUDE THE PRESENTATION OF DEFENDANTS? DEPOSITION COUNTER-DESIGNATIONS DURING PLAINTIFFS? CASE-IN-CHIEF (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:01 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 07-18092807 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 5 TO EXCLUDE TESTIMONY OF GLENN DAVID BRAUNSTEIN, M.D (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:03 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 08-18092808 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 6 TO EXCLUDE EVIDENCE, ARGUMENTS OR REFERENCES THAT RISPERDAL IS SAFE AND EFFECTIVE (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:05 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 09-18092809 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 7 TO EXCLUDE EVIDENCE, ARGUMENTS, REFERENCES, OR INFERENCES TO THE FDA?S NOVEMBER 25, 2014 RESPONSE TO A CITIZEN PETITION (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:06 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 10-18092810 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 8 MOTION IN LIMINE TO EXCLUDE EVIDENCE, ARGUMENTS, OR REFERENCES TO SPECIFIC INCIDENTS OF CONDUCT, IRRELEVANT CHARACTER EVIDEN (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:08 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 11-18092811 MOTION IN LIMINE PLAINTIFF?S MOTION IN LIMINE NO. 9 TO EXCLUDE EVIDENCE, ARGUMENTS, REFERENCES, OR INFERENCES THAT PLAINTIFF?S LACK OF PROLACTIN TEST IS EVIDENCE PLAINTIFF DID N (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:10 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 12-18092812 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 10 TO EXCLUDE EVIDENCE RELATING TO PLAINTIFF?S FAMILY?S MEDICAL AND PSYCHOLOGICAL HISTORY AND TREATMENT (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:12 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 13-18092813 MOTION IN LIMINE PLAINTIFF?S MOTION IN LIMINE NO. 11 TO EXCLUDE EVIDENCE RELATING TO CLAIMS THAT DEFENDANTS CANNOT CHANGE THEIR LABEL (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:14 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 14-18092814 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 12 TO EXCLUDE EVIDENCE RELATING TO PLAINTIFF?S PARENTS VIEWING TELEVISION ADS RELATED TO LAWSUITS AND LAWYERS SUING FOR INJURIE (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:15 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 15-18092815 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE 13 TO EXCLUDE EVIDENCE RELATED TO RISKS OF MEDICATIONS OTHER THAN RISPERDAL (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:17 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 16-18092816 MOTION IN LIMINE PLAINTIFFS? MOTION IN LIMINE NO. 14 TO EXCLUDE INADMISSBLE TESTIMONY AND EVIDENCE RELATED TO THE PRESCRIPTION AND EFFECTS OF RISPERDAL (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
12:24 AM | MTLIM - MOTION IN LIMINE | ITKIN, JASON A | |
Docket Entry: | 17-18092817 MOTION IN LIMINE PLAINTIFF?S MOTION IN LIMINE NO. 4 MOTION IN LIMINE TO EXCLUDE EVIDENCE, ARGUMENTS OR REFERENCES REGARDING RISPERDAL?S EFFECTIVENESS IN TREATING PLAINTIFFS? M (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
25-SEP-2018
10:33 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 87-18092787 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:44 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 93-18092793 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:44 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 94-18092794 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:44 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 95-18092795 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:44 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 96-18092796 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:44 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 97-18092797 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:44 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 98-18092798 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:44 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 99-18092799 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:44 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 00-18092800 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:54 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 01-18092801 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:54 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 02-18092802 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:54 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 04-18092804 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:54 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 05-18092805 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:54 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 06-18092806 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:54 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 07-18092807 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:54 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 08-18092808 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:54 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 09-18092809 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:57 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 10-18092810 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:57 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 11-18092811 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:57 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 12-18092812 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:57 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 13-18092813 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:57 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 14-18092814 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:57 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 15-18092815 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:57 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 16-18092816 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
25-SEP-2018
10:57 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 17-18092817 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: SEPTEMBER 25, 2018 | ||
09-OCT-2018
08:28 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 05-18092805 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:30 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 06-18092806 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:32 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 17-18092817 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:34 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 07-18092807 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:37 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 08-18092808 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:40 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 09-18092809 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:42 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 10-18092810 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:44 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 11-18092811 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:46 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 12-18092812 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:48 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 13-18092813 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:50 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 14-18092814 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:52 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 15-18092815 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:54 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 16-18092816 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
08:57 PM | VODIR - PROPOSED VOIR DIRE FILED | ABERNETHY, DAVID F | |
Docket Entry: | PROPOSED VOIR DIRE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
09:04 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 34-18101134 MOTION IN LIMINE NO. 12 TO PRECLUDE EVIDENCE AND ARGUMENT RELATED TO THE JANUARY 5, 1999 AND APRIL 19, 2004 LETTERS FROM DDMAC AND ALL RELATED MATERIALS (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
09:09 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 35-18101135 MOTION IN LIMINE NO. 13 TO EXCLUDE EVIDENCE OF OTHER MATTERS REGARDING RISPERDAL AND OTHER PRODUCTS MANUFACTURED, MARKETED, OR DISTRIBUTED BY ANY J&J CO. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
09:15 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 37-18101137 MOTION IN LIMINE NO. 14 TO EXCLUDE EVIDENCE OF JANSSEN'S 2013 GUILTY PLEA AND CIVIL SETTLEMENT RELATING TO RISPERDAL (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
09:20 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 38-18101138 MOTION IN LIMINE NO. 15 TO PRECLUDE PLAINTIFFS FROM INTRODUCING OR MAKING REFERENCE TO THE PROCEEDINGS AT A NOVEMBER 18, 2008 MEETING OF THE PEDIATRIC ADVISORY (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
09:23 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 39-18101139 MOTION IN LIMINE NO. 16 TO PRECLUDE EXPERT TESTIMONY OR ARGUMENT AS TO IMPROPER LEGAL OPINIONS AND DEFENDANTS' ALLEGED VIOLATIONS OF LAW (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
09:31 PM | MTLIM - MOTION IN LIMINE | ABERNETHY, DAVID F | |
Docket Entry: | 43-18101143 MOTION IN LIMINE NO. 17 TO PRECLUDE PLAINTIFFS FROM INTRODUCING EXPERT TESTIMONY, ARGUMENT, OR OTHER EVIDENCE OF CORPORATE INTENT OF DEFENDANTS, (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
09:34 PM | DEPDN - DEPOSITION DESIGNATIONS | ABERNETHY, DAVID F | |
Docket Entry: | OBJECTIONS AND COUNTER DEPOSITION DESIGNATIONS FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
09:52 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 87-18092787 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
09:54 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 93-18092793 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
09:55 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 94-18092794 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
09:56 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 95-18092795 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
09:57 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 96-18092796 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
09:58 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 97-18092797 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
09:59 PM | REPLM - MOTION/PETITION REPLY FILED | ABERNETHY, DAVID F | |
Docket Entry: | 04-18092804 REPLY IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
09-OCT-2018
10:01 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 98-18092798 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
10:02 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 99-18092799 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
10:04 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 00-18092800 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
10:06 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 01-18092801 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
10:08 PM | MTANS - ANSWER (MOTION/PETITION) FILED | ITKIN, JASON A | |
Docket Entry: | 02-18092802 ANSWER IN OPPOSITION OF MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
10:10 PM | VODIR - PROPOSED VOIR DIRE FILED | ITKIN, JASON A | |
Docket Entry: | PROPOSED VOIR DIRE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
09-OCT-2018
10:17 PM | DEPDN - DEPOSITION DESIGNATIONS | ITKIN, JASON A | |
Docket Entry: | OBJECTIONS AND COUNTER DEPOSITION DESIGNATIONS FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
10-OCT-2018
10:06 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 34-18101134 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: OCTOBER 10, 2018 | ||
10-OCT-2018
10:06 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 35-18101135 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: OCTOBER 10, 2018 | ||
10-OCT-2018
10:06 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 37-18101137 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: OCTOBER 10, 2018 | ||
10-OCT-2018
10:06 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 38-18101138 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: OCTOBER 10, 2018 | ||
10-OCT-2018
10:09 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 39-18101139 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: OCTOBER 10, 2018 | ||
10-OCT-2018
10:09 AM | MTASN - MOTION ASSIGNED | ||
Docket Entry: | 43-18101143 MOTION IN LIMINE ASSIGNED TO JUDGE: NEW, ARNOLD L. ON DATE: OCTOBER 10, 2018 | ||
10-OCT-2018
04:53 PM | PRATT - PRAECIPE TO SUPPL/ATTACH FILED | ITKIN, JASON A | |
Docket Entry: | 99-18092799 PRAECIPE TO SUPPLEMENT/ATTACH RE: MOTION IN LIMINE FILED. (FILED ON BEHALF OF AUNDREA TROTTER AND J.T.) | ||
12-OCT-2018
12:12 PM | STPLR - STIPULATION FILED | ABERNETHY, DAVID F | |
Docket Entry: | 13-18092813 STIPULATION TO DEEM CERTAIN MOTIONS IN LIMINE AS FILED FILED. AWAITING JUDICIAL APPROVAL (FILED ON BEHALF OF JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L, JOHNSON & JOHNSON COMPANY AND JANSSEN PHARMACEUTICALS, INC.) | ||
15-OCT-2018
09:43 AM | WSPTJ - SETTLED PRIOR TO ASSGN TRL JUD | NEW, ARNOLD L | |
Docket Entry: | The court having been advised that the within case has been settled, the case shall be so marked on the docket and removed from the applicable list and inventory of pending cases. If the instant proceedings involve an appeal from a compulsory arbitration award, any lien from the arbitration award is released. This case may be restored to the trial list only upon written order of the team/program leader. This relief shall be requested by formal motion. It is further ordered and decreed that in the following types of cases additional steps must be taken to officially conclude the case: minor's compromises, incompetent/incapacitated person's compromises, wrongful death/survival actions (see PA. R.C.P. 2039, 2064, 2206, Phila Civ. R. No.2039.1, 2206, and joint general court regulation 97-1) and joinder (see PA. R.C.P. 2231). BY THE COURT ...NEW,J 10/12/18 | ||
15-OCT-2018
09:43 AM | ZR236 - NOTICE GIVEN UNDER RULE 236 | ||
Docket Entry: | NOTICE GIVEN ON 16-OCT-2018 OF SETTLED PRIOR TO ASSGN TRL JUD ENTERED ON 15-OCT-2018. | ||
28-OCT-2019
03:16 PM | XLIST - TRIAL/HEARING EXHIBIT LIST | ||
Docket Entry: | none. |